Treatment of a patient with epidermodysplasia verrucifomis carrying a novel EVER2 mutation with imiquimod

被引：32

作者：

Berthelot, Cindy

Dickerson, Mary C.

Rady, Peter

He, Qin

Niroomand, Farhad

Tyring, Stephen K.

Pandya, Amit G.

机构：

[1] Univ Texas, SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr Dallas, Sch Med, Dallas, TX 75390 USA

[3] Univ Texas, Hlth Sci Ctr, Dept Dermatol, Houston, TX USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2007年 / 56卷 / 05期

关键词：

D O I：

10.1016/j.jaad.2007.01.036

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Epidermodysplasia verruciformis (EV) is a rare disorder characterized by widespread human papillomavirus infection and malignant transformation. EV may be caused by mutations of the genes EVER1 or EVER2, which are located on the EV1 locus, 17q25. We describe a patient with EV and a novel hornozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.

引用

收藏

页码：882 / 886

页数：5

相关论文

共 18 条

[1] Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a [J].

Anadolu, R ;

Oskay, T ;

Erdem, C ;

Boyvat, A ;

Terzi, E ;

Gürgey, E .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (02) :296-299

[2] NESTED PCR APPROACH FOR DETECTION AND TYPING OF EPIDERMODYSPLASIA VERRUCIFORMIS-ASSOCIATED HUMAN PAPILLOMAVIRUS TYPES IN CUTANEOUS CANCERS FROM RENAL-TRANSPLANT RECIPIENTS [J].

BERKHOUT, RJM ;

TIEBEN, LM ;

SMITS, HL ;

BAVINCK, JNB ;

VERMEER, BJ ;

TERSCHEGGET, J .

JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :690-695

[3] HPV typing in Brazilian patients with epidermodysplasia verruciformis: High prevalence of EV-HPV 25 [J].

de Oliveira, WRP ;

He, Q ;

Rady, PL ;

Hughes, TK ;

Neto, CF ;

Rivitti, EA ;

Tyring, SK .

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2004, 8 (02) :110-115

[4] Nomenclature for the description of human sequence variations [J].

den Dunnen, JT ;

Antonarakis, E .

HUMAN GENETICS, 2001, 109 (01) :121-124

[5]

Gubinelli E, 2003, J Dermatolog Treat, V14, P184, DOI 10.1080/09546630310009699

[6] Epidermodysplasia verruciformis in two half brothers with HIV infection [J].

Hu, WM ;

Nuovo, G ;

Willen, M ;

Somach, S .

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2004, 8 (05) :357-360

[7]

Iraji F, 2000, CLIN EXP DERMATOL, V25, P41

[8]

Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157

[9] Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy [J].

Karrer, S ;

Szeimies, RM ;

Abels, C ;

Wlotzke, U ;

Stolz, W ;

Landthaler, M .

BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (05) :935-938

[10] Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges [J].

Kuzmiak, Holly A. ;

Maquat, Lynne E. .

TRENDS IN MOLECULAR MEDICINE, 2006, 12 (07) :306-316